September 2015 newsletter from Cresset
News on software and services for small molecule discovery and design.
August 2015 newsletter from Cresset
Cresset's latest news on software and services for small molecule discovery and design.
Fragments from CCDC’s Cambridge Structural Database accessible through Cresset’s Spark
Cresset releases the new Spark CSD Fragment Database derived from the Cambridge Crystallographic Data Centre’s (CCDC) Cambridge Structural Database (CSD).
Activity Atlas for complex SAR interpretation – new in Forge 10.4 from Cresset
Cresset, innovative provider of software and services for small molecule discovery and design, is pleased to announce the release of Forge V10.4, the latest version of the leading computational chemistry workbench for ligand-based design.
Cresset releases Torch V10.4
Cresset's outstanding new tools help medicinal chemists make the best compound design decisions.
Cresset to distribute COSMOlogic scientific software in North America
Cresset, innovative provider of software and services for small molecule discovery and design, is pleased to announce that they will be distributing COSMOlogic software in North America alongside the existing Cresset software range.
Cresset publishes May newsletter
Chemistry software news for computational chemists, medicinal chemists and synthetic chemists.
Cresset announces scientific programmes for User Group Meetings
Cresset, innovative provider of computational chemistry software and services, is pleased to announce their North American and European User Group Meetings, both taking place in June 2015.
F2G licenses Cresset’s Forge to complement successful consulting projects
F2G, a UK biotech focusing on the discovery and development of novel compounds to treat life-threatening fungal diseases, has chosen to license Cresset’s Forge software to help develop the next generation of antifungal agents.
Mercachem chooses Cresset’s Torch and Spark molecule design software
Mercachem chooses Cresset’s Torch and Spark molecule design software to support its growing medicinal chemistry service business.
Re-Pharm uses Cresset’s Forge to identify novel activity for an existing drug
Re-Pharm Ltd has used Cresset's Forge to identify novel anti-inflammatory activity for an existing drug, which is widely prescribed for other non-inflammatory conditions.
Cresset publishes January newsletter
Cresset, innovative provider of computational chemistry software and services, has published its latest newsletter.
Guiding optimal compound design and development: A one-day symposium
Cresset, Optibrium, Lhasa Limited and COSMOlogic, providers of chemistry software and services, are partnering to present ‘Guiding Optimal Compound Design and Development: A One-day Symposium’ on 19th March 2015 at the British Consulate General in Cambridge, MA, USA.
Monash University, Australia, licenses Cresset's computational tools
Monash University Faculty of Pharmacy and Pharmaceutical Sciences, Australia, licenses Cresset’s computational tools.
Proximagen licenses Cresset’s computational tools
Proximagen licenses Cresset’s computational tools for scaffold identification and bioisostere replacement.
Spark V10.3 offers unprecedented control over scaffold hopping searches
Cresset, provider of computational chemistry software and services, announces the release of Spark V10.3 for scaffold hopping and R-group exploration. New fragment databases give 25% increase in available chemical space.
Nagoya University’s ITbM, Japan, licenses Cresset’s computational chemistry software
Cresset, innovative provider of computational chemistry software and services, is pleased to announce that Nagoya University’s Institute of Transformative Bio-Molecules (ITbM), creator of cutting edge science, located in Nagoya, Japan, has licensed Cresset’s Forge, the powerful computational chemistry suite for understanding SAR and molecular design.
Cresset donates to Novartis’ TExts to Sub-Saharan Africa (TESSA) project
Cresset,innovative provider of computational chemistry software and services, has provided a donation to Novartis Institutes for Biomedical Research (NIBR) in support of their TExts to Sub-Saharan Africa (TESSA) project. This project donates textbooks to Kenyan university libraries.
Selvita licenses Cresset’s computational tools for SAR analysis and ligand-based design
Selvita S.A., a drug discovery company located in Krakow, Poland, has licensed Cresset’s Forge and Spark products.
Cresset publishes August newsletter
New KNIME and Pipeline Pilot release plus ACS Fall presentations.
CloudScientific appointed as Cresset’s distributor in China
Cresset, innovative provider of computational chemistry software and services, announces the appointment of CloudScientific as distributor of their computational chemistry software in China.